Frontlight ResearchEarly access
CompletedNo phase
Smart Insoles for Improving Sensation, Balance and Mobility in People With Diabetic Peripheral Neuropathy.
Key facts
- Who runs it
- Walk With Path
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 19 people enrolled
- Started
- 1 Oct 2022
- Ended
- 30 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vibration on
- Vibration off
- Record updated
- 3 March 2025
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Diagnosis of diabetes type 1 or 2
- ≥1 palpable foot pulses
- Presence of mild to moderate diabetic peripheral neuropathy defined by a vibration perception threshold ≥15 Volts and/or mNDS score ≥3
- Aged ≥ 18 years
- Ability to walk unaided for 30 steps
- Able to understand the study requirements
- Ability to check their feet regularly (or have another person check)
- Able to read the study documents
- Fit shoe size EU 36-47.5 / UK 3.5-13
Who cannot take part
- Active foot ulcer
- Dementia or other cognitive impairment
- Significant cardiopulmonary or other systemic disease limiting the patient's ability to walk 30 steps
- Lower limb amputation (anything more than amputation of two lesser toes)
- Presence of Charcot deformity
- Person's with bodyweight greater than 130kg (due to insole device limitations)
- Presence of implantable neurostimulators
- Presence of a pacemaker
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The long-term effects of vibrating insoles on improving gait, balance and peripheral sensation in people with diabetic peripheral neuropathy remain unknown. The Pathfeel Clinical Trial will investigate the efficacy of vibratory insoles worn for ten days for enhancing sensory perception, gait quality, balance and physical activity in people with mild to severe diabetic neuropathy. The primary outcome will be changes in gait speed and postural and dynamic balance.
The 2 groups in the trial
- VibrationExisting treatment, for comparison
Insoles with vibration
Treatment: Vibration on
- No VibrationPlacebo, for comparison
Insoles without vibration
Treatment: Vibration off
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Efficacy of Foot Sole Vibration on Balance and Physical Activity in People With Diabetic Peripheral Neuropathy.
- Record updated
- 3 March 2025